Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Combination therapy in mice: what can we learn that may be useful for understanding rheumatoid arthritis?

× No keyword cloud information.

75 in total

1. Rheumatoid arthritis complicated by infection with the human immunodeficiency virus and the development of Sjögren's syndrome.

Authors: L H Calabrese; W S Wilke; A D Perkins; R R Tubbs
Journal: Arthritis Rheum Date: 1989-11

2. Lymphocyte involvement in rheumatoid arthritis. Studies during thoracic duct drainage.

Authors: H E Paulus; H I Machleder; S Levine; D T Yu; N S MacDonald
Journal: Arthritis Rheum Date: 1977 Jul-Aug

Review 3. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis.

Authors: P K Gregersen; J Silver; R J Winchester
Journal: Arthritis Rheum Date: 1987-11

4. Effect of antithymocyte serum on collagen arthritis in rats: evidence that T cells are involved in its pathogenesis.

Authors: E Brahn; D E Trentham
Journal: Cell Immunol Date: 1984-07 Impact factor: 4.868

5. Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats.

Authors: S Persson; A Mikulowska; S Narula; A O'Garra; R Holmdahl
Journal: Scand J Immunol Date: 1996-12 Impact factor: 3.487

6. Successful therapy of collagen-induced arthritis with TNF receptor-IgG fusion protein and combination with anti-CD4.

Authors: R O Williams; J Ghrayeb; M Feldmann; R N Maini
Journal: Immunology Date: 1995-03 Impact factor: 7.397

7. Suppression of murine collagen-induced arthritis with monoclonal anti-Ia antibodies and augmentation with IFN-gamma.

Authors: S M Cooper; S Sriram; G E Ranges
Journal: J Immunol Date: 1988-09-15 Impact factor: 5.422

8. Type II collagen-induced arthritis in mice. III. Suppression of arthritis by using monoclonal and polyclonal anti-Ia antisera.

Authors: P H Wooley; H S Luthra; W P Lafuse; A Huse; J M Stuart; C S David
Journal: J Immunol Date: 1985-04 Impact factor: 5.422

9. The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis.

Authors: N Sommer; P A Löschmann; G H Northoff; M Weller; A Steinbrecher; J P Steinbach; R Lichtenfels; R Meyermann; A Riethmüller; A Fontana
Journal: Nat Med Date: 1995-03 Impact factor: 53.440

10. Treatment of murine lupus with CTLA4Ig.

Authors: B K Finck; P S Linsley; D Wofsy
Journal: Science Date: 1994-08-26 Impact factor: 47.728

3 in total

Review 1. Regulatory aspects of evaluating combination treatments in autoimmune diseases.

Authors: P Kurki
Journal: Springer Semin Immunopathol Date: 2001

2. Tumour necrosis factor-alpha (TNF-alpha) enhances lymphocyte migration into rheumatoid synovial tissue transplanted into severe combined immunodeficient (SCID) mice.

Authors: S Wahid; M C Blades; D De Lord; I Brown; G Blake; G Yanni; D O Haskard; G S Panayi; C Pitzalis
Journal: Clin Exp Immunol Date: 2000-10 Impact factor: 4.330

3. Nimesulide improves the symptomatic and disease modifying effects of leflunomide in collagen induced arthritis.

Authors: Ahmed M Al-Abd; Fahad A Al-Abbasi; Salwa M Nofal; Amani E Khalifa; Richard O Williams; Wafaa I El-Eraky; Ayman A Nagy; Ashraf B Abdel-Naim
Journal: PLoS One Date: 2014-11-06 Impact factor: 3.240

3 in total